| pubmed-article:17868430 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17868430 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:17868430 | lifeskim:mentions | umls-concept:C0086511 | lld:lifeskim |
| pubmed-article:17868430 | lifeskim:mentions | umls-concept:C0442027 | lld:lifeskim |
| pubmed-article:17868430 | lifeskim:mentions | umls-concept:C0036043 | lld:lifeskim |
| pubmed-article:17868430 | lifeskim:mentions | umls-concept:C0003438 | lld:lifeskim |
| pubmed-article:17868430 | lifeskim:mentions | umls-concept:C0439851 | lld:lifeskim |
| pubmed-article:17868430 | lifeskim:mentions | umls-concept:C2825027 | lld:lifeskim |
| pubmed-article:17868430 | lifeskim:mentions | umls-concept:C1552596 | lld:lifeskim |
| pubmed-article:17868430 | lifeskim:mentions | umls-concept:C1831808 | lld:lifeskim |
| pubmed-article:17868430 | lifeskim:mentions | umls-concept:C1947931 | lld:lifeskim |
| pubmed-article:17868430 | pubmed:issue | 12 | lld:pubmed |
| pubmed-article:17868430 | pubmed:dateCreated | 2007-11-23 | lld:pubmed |
| pubmed-article:17868430 | pubmed:abstractText | Heparins and warfarin are currently used as venous thromboembolism (VTE) prophylaxis in surgery. Inhibition of factor (F) Xa provides a specific mechanism of anticoagulation and the potential for an improved benefit-risk profile. | lld:pubmed |
| pubmed-article:17868430 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17868430 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17868430 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17868430 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17868430 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17868430 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17868430 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17868430 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17868430 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17868430 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17868430 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17868430 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:17868430 | pubmed:issn | 1538-7933 | lld:pubmed |
| pubmed-article:17868430 | pubmed:author | pubmed-author:AnsellJJ | lld:pubmed |
| pubmed-article:17868430 | pubmed:author | pubmed-author:DeitchmanDD | lld:pubmed |
| pubmed-article:17868430 | pubmed:author | pubmed-author:GallusAA | lld:pubmed |
| pubmed-article:17868430 | pubmed:author | pubmed-author:DavidsonB LBL | lld:pubmed |
| pubmed-article:17868430 | pubmed:author | pubmed-author:LassenM RMR | lld:pubmed |
| pubmed-article:17868430 | pubmed:author | pubmed-author:PineoGG | lld:pubmed |
| pubmed-article:17868430 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17868430 | pubmed:volume | 5 | lld:pubmed |
| pubmed-article:17868430 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17868430 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17868430 | pubmed:pagination | 2368-75 | lld:pubmed |
| pubmed-article:17868430 | pubmed:meshHeading | pubmed-meshheading:17868430... | lld:pubmed |
| pubmed-article:17868430 | pubmed:meshHeading | pubmed-meshheading:17868430... | lld:pubmed |
| pubmed-article:17868430 | pubmed:meshHeading | pubmed-meshheading:17868430... | lld:pubmed |
| pubmed-article:17868430 | pubmed:meshHeading | pubmed-meshheading:17868430... | lld:pubmed |
| pubmed-article:17868430 | pubmed:meshHeading | pubmed-meshheading:17868430... | lld:pubmed |
| pubmed-article:17868430 | pubmed:meshHeading | pubmed-meshheading:17868430... | lld:pubmed |
| pubmed-article:17868430 | pubmed:meshHeading | pubmed-meshheading:17868430... | lld:pubmed |
| pubmed-article:17868430 | pubmed:meshHeading | pubmed-meshheading:17868430... | lld:pubmed |
| pubmed-article:17868430 | pubmed:meshHeading | pubmed-meshheading:17868430... | lld:pubmed |
| pubmed-article:17868430 | pubmed:meshHeading | pubmed-meshheading:17868430... | lld:pubmed |
| pubmed-article:17868430 | pubmed:meshHeading | pubmed-meshheading:17868430... | lld:pubmed |
| pubmed-article:17868430 | pubmed:meshHeading | pubmed-meshheading:17868430... | lld:pubmed |
| pubmed-article:17868430 | pubmed:meshHeading | pubmed-meshheading:17868430... | lld:pubmed |
| pubmed-article:17868430 | pubmed:meshHeading | pubmed-meshheading:17868430... | lld:pubmed |
| pubmed-article:17868430 | pubmed:meshHeading | pubmed-meshheading:17868430... | lld:pubmed |
| pubmed-article:17868430 | pubmed:meshHeading | pubmed-meshheading:17868430... | lld:pubmed |
| pubmed-article:17868430 | pubmed:meshHeading | pubmed-meshheading:17868430... | lld:pubmed |
| pubmed-article:17868430 | pubmed:meshHeading | pubmed-meshheading:17868430... | lld:pubmed |
| pubmed-article:17868430 | pubmed:meshHeading | pubmed-meshheading:17868430... | lld:pubmed |
| pubmed-article:17868430 | pubmed:meshHeading | pubmed-meshheading:17868430... | lld:pubmed |
| pubmed-article:17868430 | pubmed:meshHeading | pubmed-meshheading:17868430... | lld:pubmed |
| pubmed-article:17868430 | pubmed:meshHeading | pubmed-meshheading:17868430... | lld:pubmed |
| pubmed-article:17868430 | pubmed:meshHeading | pubmed-meshheading:17868430... | lld:pubmed |
| pubmed-article:17868430 | pubmed:meshHeading | pubmed-meshheading:17868430... | lld:pubmed |
| pubmed-article:17868430 | pubmed:meshHeading | pubmed-meshheading:17868430... | lld:pubmed |
| pubmed-article:17868430 | pubmed:meshHeading | pubmed-meshheading:17868430... | lld:pubmed |
| pubmed-article:17868430 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17868430 | pubmed:articleTitle | The efficacy and safety of apixaban, an oral, direct factor Xa inhibitor, as thromboprophylaxis in patients following total knee replacement. | lld:pubmed |
| pubmed-article:17868430 | pubmed:affiliation | Department of Orthopaedics and Clinical Trial Unit, Nordsjaellands Hospital Hoersholm, University of Copenhagen, Usseroed Kongevej 102, Hoersholm, Denmark. mirula@noh.regionh.dk | lld:pubmed |
| pubmed-article:17868430 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17868430 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:17868430 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| pubmed-article:17868430 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17868430 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17868430 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17868430 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17868430 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17868430 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17868430 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17868430 | lld:pubmed |
